Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Endocrinol ; 232(2): 297-308, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27885055

RESUMO

Sexual dimorphism in mitochondrial biogenesis and function has been described in many rat tissues, with females showing larger and more functional mitochondria. The family of the peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1) plays a central role in the regulatory network governing mitochondrial biogenesis and function, but little is known about the different contribution of hepatic PGC1A and PGC1B in these processes. The aim of this study was to elucidate the role of 17ß-estradiol (E2) in mitochondrial biogenesis and function in liver and assess the contribution of both hepatic PGC1A and PGC1B as mediators of these effects. In ovariectomized (OVX) rats (half of which were treated with E2) estrogen deficiency led to impaired mitochondrial biogenesis and function, increased oxidative stress, and defective lipid metabolism, but was counteracted by E2 treatment. In HepG2 hepatocytes, the role of E2 in enhancing mitochondrial biogenesis and function was confirmed. These effects were unaffected by the knockdown of PGC1A, but were impaired when PGC1B expression was knocked down by specific siRNA. Our results reveal a widespread protective role of E2 in hepatocytes, which is explained by enhanced mitochondrial content and oxidative capacity, lower hepatic lipid accumulation, and a reduction of oxidative stress. We also suggest a novel hepatic protective role of PGC1B as a modulator of E2 effects on mitochondrial biogenesis and function supporting activation of PGC1B as a therapeutic target for hepatic mitochondrial disorders.


Assuntos
Estradiol/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Mitocôndrias/metabolismo , Coativadores de Receptor Nuclear/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Animais , Feminino , Metabolismo dos Lipídeos/fisiologia , Fígado/metabolismo , Camundongos Transgênicos , Coativadores de Receptor Nuclear/genética , Biogênese de Organelas , Ovariectomia , Oxirredução , Estresse Oxidativo/fisiologia , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo/genética , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo/metabolismo , RNA Interferente Pequeno , Ratos
2.
Biochem Cell Biol ; 90(2): 164-72, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22235846

RESUMO

Ectopic deposition of lipids in liver and other extrahepatic tissues alters their function and occurs once adipose tissue fat storage capacity is exceeded. We investigated sexual dimorphism in the effects of dietary obesity on the liver insulin signaling pathway, as well as its connection to differences in hepatic fat accumulation. Ten-week-old Wistar rats of both sexes were fed a standard diet or a high-fat diet for 26 weeks. Insulin, adipokine levels, and glucose tolerance were measured. Lipid content, PPARα mRNA expression and protein levels of insulin receptor subunit ß (IRß), IR substrate 2 (IRS-2), Ser/Thr kinase A (Akt), and pyruvate dehydrogenase kinase isozyme 4 (PDK4) were measured in liver. In control rats, serum parameters and hepatic levels of IRß, IRS-2, and Akt proteins pointed to a profile of better insulin sensitivity in females. In response to dietary treatment, female rats exhibited a greater increase in body mass and adiposity and lower liver fat accumulation than males, but maintained better glucose tolerance. The reduced insulin signaling capacity in the liver of obese female rats seems to prevent lipid accumulation and probably lipotoxicity-associated hepatic disorders.


Assuntos
Resistência à Insulina , Metabolismo dos Lipídeos , Fígado/metabolismo , Obesidade/metabolismo , Adiponectina/sangue , Adiposidade , Animais , Glicemia , Peso Corporal , Dieta Hiperlipídica/efeitos adversos , Ingestão de Energia , Feminino , Variação Genética , Insulina/sangue , Proteínas Substratos do Receptor de Insulina/metabolismo , Fígado/patologia , Masculino , Obesidade/etiologia , Tamanho do Órgão , PPAR alfa/genética , PPAR alfa/metabolismo , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Piruvato Desidrogenase Quinase de Transferência de Acetil , Ratos , Ratos Wistar , Receptor de Insulina/metabolismo , Fatores Sexuais , Triglicerídeos/sangue
3.
Exp Biol Med (Maywood) ; 236(10): 1133-8, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21893570

RESUMO

Serum paraoxonase 1 (PON1) has been reported to be an important contributor to the antioxidant and anti-inflammatory activities of HDL, avoiding LDL oxidation. The activity of this enzyme is reduced in patients with renal insufficiency, caused by elevated oxidative stress and disturbances of apolipoprotein metabolism. Therapeutic utilization of antioxidants to control renal oxidative stress may be an effective therapy in renal protection. The aim was to investigate the protective effects of several antioxidant compounds against the oxidative stress associated to renal failure induced by ethylene glycol (EG), focusing on the possible role of serum PON1 activity. Fifty-four male Wistar rats were randomly assigned to six groups (n = 9): an untreated control (C) group, an EG-treated group, a catechin (CAT)-treated group, an epicatechin (EPI)-treated group, a quercetin (QUE)-treated group and a folk herbal extract (FHE)-treated group. After 16 d of treatment, calcium oxalate lithiasis was induced in the rats using EG. After eight days (treatment + EG), the animals were sacrificed. EG treatment impaired kidney composition, increased oxidative damage, and decreased serum paraoxonase and arylesterase activities. CAT, QUE and the FHE Fagolitos improved oxidative status by enhancing antioxidant defenses - superoxide dismutase and PON1 activities - and reducing oxidative damage, thus reinforcing the idea of a possible role of PON1 in the protective effects of QUE against the deleterious consequences of oxidative stress in kidney.


Assuntos
Antioxidantes/uso terapêutico , Arildialquilfosfatase/metabolismo , Hiperoxalúria/tratamento farmacológico , Fitoterapia , Quercetina/uso terapêutico , Animais , Apolipoproteína A-I/sangue , Arildialquilfosfatase/sangue , Western Blotting , Catequina/uso terapêutico , HDL-Colesterol/sangue , Clusterina/sangue , Modelos Animais de Doenças , Ativação Enzimática/efeitos dos fármacos , Etilenoglicol/farmacologia , Masculino , Estresse Oxidativo/efeitos dos fármacos , Preparações de Plantas , Ratos , Ratos Wistar , Insuficiência Renal/induzido quimicamente
4.
Steroids ; 76(10-11): 1051-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21540046

RESUMO

Taking into account the sexual dimorphism previously reported regarding mitochondrial function and biogenesis in brown adipose tissue, the aim of the present study was to go further into these differences by investigating the effect of ovariectomy and 17-ß estradiol (E2) replacement on brown adipose tissue mitochondrial function. In this study, fourteen-week-old control female and ovariectomized female Wistar rats were used. Rats were ovariectomized at 5 weeks of age and were treated every 2 days with placebo (OVX group) or E2 (10 µg/kg) (OVX+E2 group) for 4 weeks before sacrifice. We studied the levels of oxidative capacity, antioxidant defence and oxidative damage markers in brown adipose tissue. Moreover, the levels of key elements of mitochondrial biogenesis as well as UCP1 protein levels, as an index of mitochondrial thermogenic capacity, were also determined. In response to ovariectomy, mitochondrial proliferation increased, resulting in less functional mitochondria, since oxidative capacity and antioxidant defences decreased. Although E2 supplementation was able to restore the serum levels of E2 shown by control rats, the treatment reverted the effects of the ovariectomy only in part, and oxidative and antioxidant capacities in OVX+E2 rats did not reach the levels shown by control females. Taking these results into account, we suggest that ovarian hormones are responsible, at least in part, for the sexual dimorphism in BAT mitochondrial function. However, other signals produced by ovary, rather than E2, would play an important role in the control of mitochondrial function in BAT.


Assuntos
Tecido Adiposo Marrom/efeitos dos fármacos , Tecido Adiposo Marrom/metabolismo , Estradiol/farmacologia , Mitocôndrias/metabolismo , Ovariectomia/efeitos adversos , Animais , Western Blotting , Peso Corporal , Estradiol/sangue , Feminino , Reação em Cadeia da Polimerase , Ratos
5.
Cell Physiol Biochem ; 26(3): 291-302, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20798513

RESUMO

BACKGROUND/AIMS: Mitochondrial biogenesis includes both mitochondrial proliferation and differentiation and its regulation under different physiological conditions is not clear. Given the sexual dimorphism previously found in mitochondrial function, the aim of this study was to investigate the gender-dependent effect of chronic high-fat-diet (HFD) feeding on rat liver mitochondrial function and biogenesis. METHODS: Ten-week old male and female rats were fed a HFD (26% fat) or a control diet (2.9% fat) for 26 weeks. Mitochondrial morphology was studied. Mitochondrial DNA and protein content, hydrogen peroxide production, oxidative capacity, antioxidant defenses, as well as markers of oxidative damage and mitochondrial biogenesis were analyzed. RESULTS: Female rats showed higher levels of mitochondrial protein and an enhanced oxidative capacity per mitochondrion than males. In both genders, HFD feeding increased mtDNA content and decreased mitochondrial differentiation markers. CONCLUSION: In comparison to male rats, females show higher oxidative capacity as a consequence of their greater mitochondrial differentiation under both control and obese status. In response to HFD feeding, the oxidative capacity of the whole mitochondrial population is maintained in both genders. This is obtained by means of an enhancement of mitochondrial proliferation, which counteracts the diet-induced impairment of the function of each mitochondrion.


Assuntos
Mitocôndrias Hepáticas/metabolismo , Animais , Citrato (si)-Sintase/metabolismo , Gorduras na Dieta/farmacologia , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Estradiol/sangue , Feminino , Glutationa Peroxidase/metabolismo , Peróxido de Hidrogênio/metabolismo , Masculino , Estresse Oxidativo , Ratos , Ratos Wistar , Fatores Sexuais , Superóxido Dismutase/metabolismo , Fatores de Tempo
6.
Pflugers Arch ; 453(6): 831-7, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17146679

RESUMO

High-density lipoprotein-associated paraoxonase 1 (PON1) protects the endothelium from the pro-oxidant activity of oxidised low-density lipoprotein. Whereas fasting has been related to increased oxidative stress, intermittent fasting and caloric restriction are associated to increased resistance to oxidative injury. Taking into consideration that serum PON1 activity is modulated by a restriction of caloric intake and because there is no evidence regarding PON1 response to total food deprivation, we investigated whether PON1 activity is involved in the response aimed to counteract the greater oxidative stress associated to fasting and whether serum PON1 activity is altered by the length of food deprivation. Male Wistar rats were randomly divided into five groups: fed and 6-, 12-, 24- or 48-h fasted rats. Serum PON1 activity increases within the first hours of fasting, representing a prompt adaptation designed to attenuate blood lipid peroxidation that cannot be sustained when fasting is prolonged. This PON1 response to early fasting could be part of the mechanisms triggered by periodically repeated short periods of food deprivation - intermittent fasting - which result in increased resistance to stress by stimulating antioxidant defences.


Assuntos
Arildialquilfosfatase/sangue , Jejum/fisiologia , Privação de Alimentos/fisiologia , Peroxidação de Lipídeos/fisiologia , Animais , Apolipoproteína A-I/sangue , Arildialquilfosfatase/genética , Hidrolases de Éster Carboxílico/sangue , Catalase/metabolismo , Clusterina/sangue , Expressão Gênica/fisiologia , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Fígado/anatomia & histologia , Fígado/enzimologia , Masculino , Tamanho do Órgão , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Receptores Depuradores Classe B/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...